KOrean Borderline Ovarian Tumor (KOBOT) Registry

Recruiting now

Conditions studied: Ovarian Neoplasms

In brief

The aim of this study is to collect data on Korean patients with borderline ovarian tumors.

Key facts

Study ID

NCT02803970

Run by

Kangbuk Samsung Hospital

People needed

3000

Starts

1994-12-01

Expected to finish

2040-12-01

Last updated by the study team

2019-04-03

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients with borderline ovarian tumors (BOTs) diagnosed, treated, and followed between November 1994 and February 2015 at institutions where placed in the Republic of Korea.
• All patients undergoing gynecologic surgery for BOTs at institutions where placed in the Republic of Korea since March, 2015

You may not qualify if…

• Patients who did not receive primary treatment or follow-up for at least 6 months at each institution were excluded from analysis

Where it is running

• Samsung Changwon Hospital — Changwon, South Korea (enrolling)
• Kangbuk Samsung Hospital — Seoul, South Korea (enrolling)
• CHA Gangnam Medical Center — Seoul, South Korea (enrolling)
• Samsung Medical Center — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.